Cargando…
Intravitreal Bevacizumab Injection Attenuates Diabetic Retinopathy in Adult Rats with Experimentally Induced Diabetes in the Early Stage
Diabetic retinopathy is the leading cause of blindness, yet its treatment is very limited. Anti-VEGF drug has been widely applied in ocular disease, but its effects on diabetic retinopathy and the underlying mechanism have remained to be fully explored. To elucidate the role of anti-VEGF treatment,...
Autores principales: | Lv, Jiao, Chen, Miao-Miao, Mu, Zhi-Hao, Wang, Fang, Qian, Zhong-Yi, Zhou, Lei, Guo, Qiu-Ting, Zhao, Zhi-Min, Pan, Yu-Ping, Liao, Xin-Yu, Yang, Zhi-Hong, Cai, Ning, Li, Shu-De, Zou, Ying-Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994287/ https://www.ncbi.nlm.nih.gov/pubmed/29977927 http://dx.doi.org/10.1155/2018/9216791 |
Ejemplares similares
-
Difference in the Vitreal Protein Profiles of Patients with Proliferative Diabetic Retinopathy with and without Intravitreal Conbercept Injection
por: Zou, Chen, et al.
Publicado: (2018) -
Intravitreal injection of Bevacizumab in diabetic macular edema
por: Ateeq, Asim, et al.
Publicado: (2014) -
Retro-mode imaging of fibrovascular membrane in proliferative diabetic retinopathy after intravitreal bevacizumab injection
por: Suzuma, Kiyoshi, et al.
Publicado: (2011) -
Effects of an Intravitreal Bevacizumab Injection Combined With Panretinal Photocoagulation on High-Risk Proliferative Diabetic Retinopathy
por: Shin, Yong Woon, et al.
Publicado: (2009) -
Short-term intraocular pressure changes after intravitreal injection of bevacizumab in diabetic retinopathy patients
por: Farhood, Qasim Kadhim, et al.
Publicado: (2014)